Structure-activity relationships of diverse Annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells

被引:154
作者
Oberlies, NH [1 ]
Chang, CJ [1 ]
McLaughlin, JL [1 ]
机构
[1] PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT MED CHEM & MOL PHARMACOL,W LAFAYETTE,IN 47907
关键词
D O I
10.1021/jm9700169
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fourteen structurally diverse Annonaceous acetogenins, representing the three main classes of bis-adjacent, bis-nonadjacent, and singie-THF ring(s), were tested for their ability to inhibit the growth of adriamycin resistant human mammary adenocarcinoma (MCF-7/Adr) cells. This cell line is resistant to treatment with adriamycin, vincristine, and vinblastine and is, thus, multidrug resistant (MDR), Among a series of bis-adjacent THF ring acetogenins, those with the stereochemistry of threo-trans-threo-trans-erythro (from C-15 to C-24) were the most potent with as much as 250 times the potency of adriamycin. A spacing of 13 carbons between the flanking hydroxyl of the THF ring system and the gamma-unsaturated lactone seems to be optimum with a spacing of 11 and 9 carbons being significantly less active. Several single-THF ring compounds, were also quite potent with gigantetrocin A (11) being the most potent compound tested. The acetogenins may, thus, have chemotherapeutic potential, especially with regard to MDR tumors.
引用
收藏
页码:2102 / 2106
页数:5
相关论文
共 30 条
[1]   MODE OF ACTION OF BULLATACIN - A POTENT ANTITUMOR AND PESTICIDAL ANNONACEOUS ACETOGENIN [J].
AHAMMADSAHIB, KI ;
HOLLINGWORTH, RM ;
MCGOVREN, JP ;
HUI, YH ;
MCLAUGHLIN, JL .
LIFE SCIENCES, 1993, 53 (14) :1113-1120
[2]  
Alfonso Dorothee, 1996, Natural Toxins, V4, P181, DOI 10.1002/19960404NT6
[3]  
DURET P, 1994, HETEROCYCLES, V39, P741
[4]   ANNONACEOUS ACETOGENINS - AN UPDATED REVIEW [J].
FANG, XP ;
RIESER, MJ ;
GU, ZM ;
ZHAO, GX ;
MCLAUGHLIN, JL .
PHYTOCHEMICAL ANALYSIS, 1993, 4 (01) :27-48
[5]  
Goldstein L J, 1995, Curr Probl Cancer, V19, P65
[6]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427
[7]   EXPLOITING MULTIDRUG-RESISTANCE TO TREAT CANCER [J].
GOTTESMAN, MM ;
AMBUDKAR, SV ;
NI, B ;
ARAN, JM ;
SUGIMOTO, Y ;
CARDARELLI, CO ;
PASTAN, I .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 :677-683
[8]  
GU ZM, 1995, RECENT ADV PHYTOCHEM, V29, P249
[9]   Bicinchoninic acid protein assay in the determination of adriamycin cytotoxicity modulated by the MDR glycoprotein [J].
Hall, AM ;
Croy, V ;
Chan, T ;
Ruff, D ;
Kuczek, T ;
Chang, CJ .
JOURNAL OF NATURAL PRODUCTS, 1996, 59 (01) :35-40
[10]   TOTAL SYNTHESIS OF THE POTENT ANTITUMOR, BIS-TETRAHYDROFURANYL ANNONACEOUS ACETOGENINS (+)-ASIMICIN AND (+)-BULLATACIN [J].
HOYE, TR ;
TAN, LS .
TETRAHEDRON LETTERS, 1995, 36 (12) :1981-1984